Biotech Acquisition (OTCMKTS:BIOTU) shares down 7.7%

Biotech Acquisition (OTCMKTS:BIOTU – Get Free Report) fell 7.7% in midday trading on Thursday. The company was trading at $10.14 and last traded at $10.14. About 1,300 shares were traded in midday trading, down 71% from its average daily volume of 4,444 shares. The stock had previously closed at $10.98.

Price Performance of Biotech Acquisitions

The stock’s 50-day average price is $10.14 and its 200-day average price is $10.14.

Biotech Acquisitions Company Profile

(Download the free report)

Biotech Acquisition Company has no significant operations. It intends to enter into a merger, stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more companies. The Company was founded in 2020 and is headquartered in New York, New York.

See also

Get daily biotech acquisition news and ratings – Enter your email address below to receive a concise summary of the latest news and analyst ratings for Biotech Acquisition and related companies in MarketBeat.com’s FREE daily newsletter.